Home/Filings/4/0001209191-15-015709
4//SEC Filing

Asterias Biotherapeutics, Inc. 4

Accession 0001209191-15-015709

CIK 0001572552operating

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 8:58 PM ET

Size

7.8 KB

Accession

0001209191-15-015709

Insider Transaction Report

Form 4
Period: 2015-02-13
LEBKOWSKI JANE
Pres., Research & Development
Transactions
  • Award

    Stock Option (right to buy)

    2015-02-13+100,000100,000 total
    Exercise: $3.90Exp: 2025-02-12Series A Common Stock (100,000 underlying)
  • Award

    Restricted Stock Units

    2015-02-13+31,02531,025 total
    Series A Common Stock (31,025 underlying)
Footnotes (3)
  • [F1]These options will vest and become exercisable in 48 equal monthly installments beginning on the one month anniversary of the date of grant.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of AST Series A Common Stock.
  • [F3]These restricted stock units vest in four equal quarterly installments beginning June 30, 2015.

Issuer

Asterias Biotherapeutics, Inc.

CIK 0001572552

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001572552

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:58 PM ET
Size
7.8 KB